Mikrokontrastin

Mikrokontrastin is a contrast agent used in medical imaging, particularly in magnetic resonance imaging (MRI). It is designed to enhance the visibility of small structures within the body, making it particularly useful for diagnosing conditions that affect the brain, spinal cord, and other small structures. Mikrokontrastin is typically administered intravenously and is composed of a paramagnetic substance, such as gadolinium, which alters the magnetic properties of the surrounding tissue. This alteration allows for better visualization of the tissue on MRI scans, helping radiologists to identify abnormalities such as tumors, inflammation, or other pathological conditions. The use of mikrokontrastin is carefully monitored, as gadolinium can have potential side effects, including nephrogenic systemic fibrosis, which is a rare but serious condition. Therefore, its use is generally reserved for cases where the diagnostic benefit outweighs the potential risks. Mikrokontrastin is not to be confused with macrokontrastin, which is used for imaging larger blood vessels and organs.